Ken Griffin Fortress Biotech, Inc. Transaction History

Citadel Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.49 - $0.82 $7,449 - $12,467	15,204 Added 875.3%	16,941 $9,000
Q1 2023 May 15, 2023	BUY	$0.65 - $1.1 $1,129 - $1,910	1,737 New	1,737 $1,000
Q2 2022 Aug 15, 2022	BUY	$0.8 - $1.5 $58,420 - $109,539	73,026 Added 44.65%	236,569 $199,000
Q1 2022 May 16, 2022	BUY	$1.24 - $2.75 $96,695 - $214,445	77,980 Added 91.14%	163,543 $222,000
Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.65 $71,031 - $107,134	29,352 Added 52.22%	85,563 $213,000
Q3 2021 Nov 15, 2021	BUY	$2.82 - $3.7 $28,992 - $38,039	10,281 Added 22.38%	56,211 $181,000
Q2 2021 Aug 16, 2021	BUY	$3.5 - $5.48 $113,631 - $177,913	32,466 Added 241.13%	45,930 $163,000
Q2 2019 Aug 14, 2019	BUY	$1.43 - $1.94 $809 - $1,098	566 Added 4.39%	13,464 $20,000
Q4 2018 Feb 14, 2019	SELL	$0.57 - $1.53 $9,764 - $26,208	-17,130 Reduced 57.05%	12,898 $11,000
Q3 2018 Nov 13, 2018	BUY	$1.44 - $3.13 $3,238 - $7,039	2,249 Added 8.1%	30,028 $0
Q1 2018 May 11, 2018	BUY	$3.42 - $5.35 $95,004 - $148,617	27,779 New	27,779 $126,000
Q4 2017 Feb 09, 2018	SELL	$3.26 - $4.84 $74,305 - $110,318	-22,793 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$3.83 - $4.89 $87,297 - $111,457	22,793	22,793 $101,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.